4//SEC Filing
Koconis John 4
Accession 0001437749-23-010523
CIK 0001504167other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 11:43 AM ET
Size
5.4 KB
Accession
0001437749-23-010523
Insider Transaction Report
Form 4
Koconis John
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-04-15+45,010→ 45,010 totalExercise: $1.66Exp: 2032-04-14→ Common Stock (45,010 underlying)
Footnotes (1)
- [F1]25% of the options vest on April 15, 2024, and the remaining shares will become exercisable in 36 equal monthly installments beginning on May 15, 2024, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date.
Documents
Issuer
Timber Pharmaceuticals, Inc.
CIK 0001504167
Entity typeother
Related Parties
1- filerCIK 0001809589
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 11:43 AM ET
- Size
- 5.4 KB